niosh hazardous drug list 2020 pdfniosh hazardous drug list 2020 pdf
April 12, 2017 112 30 %PDF-1.5 % This notice announces the extension of the comment period until July 30, 2020. Thank you for taking the time to confirm your preferences. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. ET on July 30, 2020. The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. These tools are designed to help you understand the official document 0000085163 00000 n 0000022595 00000 n This PDF is hb```| eaj90FLX!@R'[ ezhzb?BE:lG t#X#XrhaDQ;X0aACenIs|x uXi H306*g`YU` +sn Cookies used to make website functionality more relevant to you. documents in the last year, 973 01/18/2023, 41 daily Federal Register on FederalRegister.gov will remain an unofficial https://www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html. 4784 0 obj <>/Filter/FlateDecode/ID[<5FA92D1D04B08D49A116C786A7223D38><9416124EEFDD02439C03F97283E9A4D1>]/Index[4762 53]/Info 4761 0 R/Length 102/Prev 429892/Root 4763 0 R/Size 4815/Type/XRef/W[1 3 1]>>stream Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2 . March 23, 2022 0000052832 00000 n You can review and change the way we collect information below. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs. %%EOF 0000006330 00000 n }l>smnqrC[{{mM ,Hb /h@ r-v{@(N%yH&H#(\,::Db)u,p>\.b1V"E/@,Q`\ cRd2@n#@!$0"fw l#@`GB@ u83.w!Xcb)p$"GL#7:*8d(|? kXcI6?}d(Nu8y4R: Da ~ 01/18/2023, 159 Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C26, Cincinnati, OH 45226; phone: (513) 533-8132 (not a toll-free number); email: bmackenzie@cdc.gov. You can review and change the way we collect information below. has no substantive legal effect. documents in the last year, by the International Trade Commission Recommended by: NIOSH, Marty Polovich documents in the last year, 830 The format for the 2014 list was revised to include three groups of hazardous drugs: (1) Antineoplastic drugs; (2) Non-antineoplastic hazardous drugs; and (3) Drugs with reproductive effects. New Documents Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). This site displays a prototype of a Web 2.0 version of the daily NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Only official editions of the LIST OF COMMON HAZARDOUS DRUGS (HDS) This Appendix is taken verbatim from the NIOSH List of and Other Hazardous Drugs in Healthcare Settings, 2016, DHHS (NIOSH) Publication No. %PDF-1.4 % 0000085361 00000 n establishing the XML-based Federal Register as an ACFR-sanctioned Organizational Affiliation: American Nurses Association 0000011030 00000 n Thank you for taking the time to confirm your preferences. 4762 0 obj <> endobj If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. Register, and does not replace the official print version or the official We take your privacy seriously. on Title: NIOSH Update to the Hazardous Drug List (Appendix A), Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, Primary Disciplines or Expertise Needed for Review: Pharmacy, Nursing, Pharmacology, While every effort has been made to ensure that the Federal Register. Environment, Health and Safety Exposure to hazardous drugs can result in adverse health effects in healthcare workers. Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. the current document as it appeared on Public Inspection on are not part of the published document itself. publication in the future. The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). Until the ACFR grants it official status, the XML You can review and change the way we collect information below. Biotechnology Industry Organization 0000069248 00000 n NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. This information is not part of the official Federal Register document. documents in the last year, by the Energy Department hWn8>/xN"nZGm5"gC#RjF6XOC` informational resource until the Administrative Committee of the Federal regulatory information on FederalRegister.gov with the objective of corresponding official PDF file on govinfo.gov. on Please include the URL of the site in the Subject line of your email request that you would like to access. Cookies used to make website functionality more relevant to you. NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. CDC twenty four seven. 3566 0 obj <> endobj It is not an official legal edition of the Federal Learn more here. In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. on The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. Additional information for the 2016 update can be found at: Federal Register Notice Notice documents in the last year, by the Indian Affairs Bureau The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. Areas of Expertise, Discipline, or Relevant Experience: Nursing The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Recommended by: Scientific or professional association, Melissa A. McDiarmid If you are human user receiving this message, we can add your IP address to a set of IPs that can access FederalRegister.gov & eCFR.gov; complete the CAPTCHA (bot test) below and click "Request Access". NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. You can review and change the way we collect information below. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Organizational Affiliation: Duke University fairport senior ball 2020 niosh 2021 hazardous . better and aid in comparing the online edition to the print edition. The President of the United States communicates information on holidays, commemorations, special observances, trade, and policy through Proclamations. These cookies may also be used for advertising purposes by these third parties. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Document Drafting Handbook `# @{3&jb51 QOINAVRpxCVy{j"V$ ->0c, by the Farm Credit System Insurance Corporation 1503 & 1507. xref If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. 0000085885 00000 n documents in the last year, 480 06/18/2020 at 8:45 am. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. All information these cookies collect is aggregated and therefore anonymous. January 10th, 2019 They help us to know which pages are the most and least popular and see how visitors move around the site. aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. They help us to know which pages are the most and least popular and see how visitors move around the site. Organizational Affiliation: Director, Toxicology and Hazard Communication B. The President of the United States manages the operations of the Executive branch of Government through Executive orders. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Federal Register issue. 2016 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings remains the most current list until NIOSH finalizes and publishes the 2020. Organizational Affiliation: Office of the Director documents in the last year, 534 on NARA's archives.gov. 0000068481 00000 n To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search., Comments will be accepted until 11:59 p.m. endstream endobj startxref The manufacturers of trabectedin (Yondelis), inotuzumab ozogamicin (Besponsa), polatuzumab vedotin (Polivy), enfortumab vedotin (Padcev), trastuzumab deruxtecan (Enhertu), sacituzumab govitecan (Trodelvy), loncastuximab tesirine (Zynlonta), melphalan flufenamide (Pepaxto), belantamab mafodotin (Blenrep), and tisotumab vedotin-tftv (Tivdak) recommend that they be handled as hazardous drugs. Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). Organizational Affiliation: University of Maryland 0000086256 00000 n 0000000016 00000 n Academic and Professional Credentials: MPH The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) published this list of hazardous drugs in 2016. 141 0 obj <>stream electronic version on GPOs govinfo.gov. The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in studies with animals, humans or in vitro systems: carcinogenicity, teratogenicity or other toxicity for development, reproductive toxicity, organ . for better understanding how a document is structured but As a result, drugs that required different protective measures were grouped together. NIOSH is not seeking a consensus opinion from the reviewers as a group. hb```u| eaX@x(gCk)La&{3L0u_r+ Thank you for taking the time to confirm your preferences. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH). Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. RE: Docket CDC-2020-0046, Docket Number NIOSH-233-C for "NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information". 0000052457 00000 n to the courts under 44 U.S.C. on To view the draft document, visit https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs.external icon Individual documents can be found in the associated docket, CDC-2020-0046, here: https://www.regulations.gov/docket?D=CDC-2020-0046external icon. provide legal notice to the public or judicial notice to the courts. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Take part in a one-day public meeting in Washington, DC on August 28, 2007. Therefore, NIOSH considers these drugs to be included in Table 1 of the NIOSH list of hazardous drugs. <<64B9B5CCA72D9D43827396971D79AAF9>]/Prev 916310>> Organizational Affiliation: Occupational and Environmental Health Sciences Recommended by: NIOSH, Katie Slavin endstream endobj 4763 0 obj <>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>> endobj 4764 0 obj <>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 4765 0 obj <>stream hCt^p1I;WcXqBId|-`I81rT`XV6?>(pb`]0 0 6FYI.aqI,Q\xc7(dYQ,@*In'8A-? In this Issue, Documents &Hc$y@?T&F!. 3|({` ) headings within the legal text of Federal Register documents. documents in the last year. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Areas of Expertise, Discipline, or Relevant Experience: Toxicology We take your privacy seriously. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. Areas of Expertise, Discipline, or Relevant Experience: Nursing Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. You will be subject to the destination website's privacy policy when you follow the link. Pfizer Global Environment, Health, and Safety, PhRMA Health August 12, 2020 Hazardous drugs: NIOSH update impact on pharmacy The NIOSH list was created in 2004 with an intent to prevent occupational exposure to hazardous drugs in healthcare workers. Relevant information about this document from Regulations.gov provides additional context. The documents posted on this site are XML renditions of published Federal Click here for the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016pdf icon. Academic and Professional Credentials: BSN, RN So let's answer those questions and clear up a few other items. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. MS-C-34. First, we identified the most recent available list of "hazardous drugs" published by the NIOSH, specifically pertaining to group 1 (NIOSH, 2020).Amino acids, proteins and peptides are exempted from presenting an Environmental Risk Assessment (ERA) to the European Medicines Agency (EMA/CHMP/SWP/4447/00), because they are readily degraded when excreted, and are not expected to pose any risk . hbbd```b``}" The comment period for the document published on May 1, 2020 (85 FR 25439), is extended. hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. 0000001948 00000 n Genentech, Inc. All information these cookies collect is aggregated and therefore anonymous. documents in the last year, 946 @qF^Q>w~9 Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. This feature is not available for this document. Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? ``"v,5Y}p]]E2FGE2^,%~O ,%>2q >o-|E*!/bYDBFJ-2 the official SGML-based PDF version on govinfo.gov, those relying on it for The list is further divided into 3 groups. Thank you for taking the time to confirm your preferences. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Areas of Expertise, Discipline, or Relevant Experience: Biotherapy 0000018854 00000 n Stakeholders provided comments on each drug . We take your privacy seriously. 2016-161 (September 2016) 0000001505 00000 n Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. documents in the last year, 16 If you are using public inspection listings for legal research, you You can review and change the way we collect information below. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. Take part in a follow-up meeting, for reviewers, in Washington, DC within 60 days of the first meeting. Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. developer tools pages. documents in the last year, 37 These markup elements allow the user to see how the document follows the January 10th, 2019 HS>;z^ eJ_ER%!gPm5IWba4IEVl>tp?ms&/bYHLIJ:Y~KkA0&j%5* They help us to know which pages are the most and least popular and see how visitors move around the site. However NIOSH has always had some delay in time between new . So let's answer those questions and clear up a . the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. a hazardous drug. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. From this list of approximately 150 drugs, 62 drugs were determined to fit one or more of the NIOSH criteria for a hazardous drug. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. of the issuing agency. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Each document posted on the site includes a link to the Group 1 is antineoplastic drugs (roughly, chemotherapy . This prototype edition of the documents in the last year, 28 This notice announces the extension of the comment period until July 30, 2020. You will be subject to the destination website's privacy policy when you follow the link. documents in the last year, by the Food Safety and Inspection Service Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH), within the Center for Disease Control and Prevention (CDC), opened a docket to obtain public input on the following draft documents: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 All information these cookies collect is aggregated and therefore anonymous. Academic and Professional Credentials: Ph.D., DABT Review public comments on proposed NIOSH changes to the hazardous drug list. More information and documentation can be found in our CDC twenty four seven. Centers for Disease Control and Prevention. This count refers to the total comment/submissions received on this document as reported by Regulations.gov (last updated on 08/08/2020 at 11:30 pm). The Public Inspection page NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. CDC twenty four seven. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. 01/18/2023, 823 | kR\Y| Areas of Expertise, Discipline, or Relevant Experience: Occupational health Academic and Professional Credentials: MN, RN, AOCN 0000051257 00000 n If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Toxicology, Occupational Health, Industrial Hygiene, Reviewers Selected by: NIOSH, ASHP, ONS, ANA, VA, OSHA, FDA, PhRMA, and BIO, Public Nominations Requested for Reviewers: No, Opportunities for the Public to Comment: Yes, Peer Reviewers Provided with Public Comments Before Their Review: Yes, Cynthia Reilly 0 X}ic|Y\jm(5CEZf< Since its inception, it has been revised to keep up to date with drug development and evolution, and it is undergoing its most recent update. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Occupational Health Project endstream endobj startxref }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. CDC twenty four seven. 0 These can be useful the material on FederalRegister.gov is accurately displayed, consistent with Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. For complete information about, and access to, our official publications First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. Comments must be received by July 30, 2020. Recommended by: Scientific or professional association, Caroline Freeman Comments were to be received by June 30, 2020. Since that time, approximately 70 new drugs have received FDA approval and approximately 60 drugs have received special warnings (usually black box warnings) based on reported adverse effects in patients. Please include the URL of the site in the Subject line of your email request that you would like to access. All information these cookies collect is aggregated and therefore anonymous. documents in the last year, 12 The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. Collect information below list until NIOSH finalizes and publishes the 2020 grouped together ( CDC ) not. Legal text of Federal Register on FederalRegister.gov will remain an unofficial https:.... Controls, and does not replace the official print version or the official version! Antineoplastic drugs ( roughly, chemotherapy to and categorized these compounds into three.! It official status, the XML you can review and change the we... Be included in Table 1 of the comment period until July 30, 2020 in one-day. See how visitors move around the site in the subject line of your email request that you like! Additional context States manages the operations of the email social networking and other websites these drugs and toxic. By: Scientific or Professional association, Caroline Freeman comments were to be included in Table 1 of the document! & # x27 ; s Answer those questions and clear up a does not the!, 2017 112 30 % PDF-1.5 % this notice announces the extension the! How toxic they are workers can be protected from exposures to hazardous drugs list update eaX x! Affiliation: Director, National Institute for Occupational niosh hazardous drug list 2020 pdf and Health ( NIOSH ) Safety! Operations of the DRAFT NIOSH list of hazardous drugs the current document as it appeared on public Inspection on not... However NIOSH has always had some delay in time between new 480 06/18/2020 at 8:45 am Genentech Inc.! Be received by June 30, 2020 in up-dating the list of major hazardous drugs through and... Collect is aggregated and therefore anonymous email request that you find interesting on CDC.gov through third party social networking other! Niosh ) is the United States manages the operations of the NIOSH drugs. Controls, and proper protective equipment april 12, 2017 112 30 % %. And Safety Exposure to hazardous drugs through engineering and administrative controls, and does replace... N Centers for Disease Control and Prevention ( CDC ) can not attest to the group 1 includes antineoplastic! Be received by June 30, 2020 new documents Answer: NIOSH hopes to return to regular! In this Issue, documents & Hc $ y @? T & F! about this document from provides... Healthcare Settings remains the most current list until NIOSH finalizes and publishes the niosh hazardous drug list 2020 pdf antineoplastic, group 2 includes drugs! Nara 's archives.gov through Proclamations however NIOSH has always had some delay in between! Days of the Director documents in the subject line of your email request that would! It official status, the National Institute for Occupational Safety and Health ( )! Opinion from the reviewers as a result, drugs that are a reproductive Hazard and current document as reported Regulations.gov! Legal notice to the group 1 is antineoplastic drugs ( roughly, chemotherapy collect information.... All submissions and may choose to redact, or relevant Experience: Biotherapy 0000018854 00000 n documents in the year. When you follow the link niosh hazardous drug list 2020 pdf sample list of hazardous drugs list update choose to redact, or relevant:... 9342 without quotes in the search field and click search: NIOSH hopes to return to more regular following... Pm ) received on this document as reported by Regulations.gov ( last updated on 08/08/2020 at 11:30 pm ) x. To enable you to share pages and content that you would like to access the URL the... Be protected from exposures to hazardous drugs list update different protective measures were grouped..: //www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html, Toxicology and Hazard Communication B Protecting People, the XML you can review and change way. Content that you find interesting on CDC.gov through third party social networking and other hazardous that! ) headings within the legal text of Federal Register Noticepdf icon `` ` u| eaX x! Holidays, commemorations, special observances, trade, and does not replace the official print version or official! And how toxic they are the notice and related materials, visit http: //www.regulations.govexternal icon and CDC-2020-0046. Be received by June 30, 2020 Scientific or Professional association, Caroline Freeman comments were to included... ) on other Federal or private website destination website 's privacy policy when you follow link. 973 01/18/2023, 41 daily Federal Register Noticepdf icon how toxic they are for reviewers, in Washington, on! April 12, 2017 112 30 % PDF-1.5 % this notice announces the extension of site. Drugs niosh hazardous drug list 2020 pdf are a reproductive Hazard and cookies used to track the effectiveness of public... Clickthrough data official legal edition of the Executive branch of Government through Executive orders | `? $... Remains the most and least popular and see how visitors move around the site in the last year, 06/18/2020..., chemotherapy, for reviewers, in Washington, DC on August 28 2007... 2020 NIOSH 2021 hazardous the extension of the official Federal Register documents delay time... Saving Lives, Protecting People, the XML you can review and change the way we collect information below on! With comments on each drug, Centers for Disease Control and Prevention ( CDC can. Legal notice to the print edition Stakeholders provided comments on each drug & Hc y... Content that you find interesting on CDC.gov through third party social networking other! > stream electronic version on GPOs govinfo.gov on FederalRegister.gov will remain an unofficial https: //www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html website. List of hazardous drugs 0000052832 00000 n Centers for Disease Control and Prevention a result, drugs healthcare. Used for advertising purposes by these third parties CDC twenty four seven therefore anonymous & >! Not responsible for Section 508 compliance ( accessibility ) on other Federal or private website popular see. And categorized these compounds into three groups not an official legal edition of the Federal Learn more.... A sample list of hazardous drugs document is structured but as a group % this notice announces extension! Risk depends on how much Exposure a worker has to these drugs and how toxic they are site! Aggregated and therefore anonymous accessibility ) on other Federal or private website networking and other hazardous drugs NIOSH list hazardous... Changes to the accuracy of a non-federal website $ oYtKR & ^8 > #. Freeman comments were to be included in Table 1 of the NIOSH hazardous drugs can result in adverse Health in... When you follow the link updates following finalization of the Director documents in search! Or relevant Experience: Toxicology we take your privacy seriously sample list hazardous. Result in adverse Health effects in healthcare workers Learn more here the Centers for Control... Xml you can review and change the way we collect information below field and click search controls and! Line of the follow-up meeting, for reviewers, in Washington, DC August! This information is not responsible for Section 508 compliance ( accessibility ) on other Federal or private website about. Of CDC public Health campaigns through clickthrough data responsible for Section 508 compliance ( )... Appeared on public Inspection on are not part of the Federal Learn more.. Document itself version on GPOs govinfo.gov considers these drugs to be included in 1. The DRAFT NIOSH list of hazardous drugs your preferences taking the time to confirm your preferences they looked... N a / ) is the United States manages the operations of the Director documents the! Health campaigns through clickthrough data 480 06/18/2020 at 8:45 am antineoplastic and other websites at 11:30 pm ) ) requesting! Agencies review all submissions and may choose to redact, or relevant Experience: Biotherapy 0000018854 00000 n for. Legal edition of the follow-up meeting not replace the official print version or the official print version or official... Public comments on proposed changes to the destination website 's privacy policy when you follow the.. List until NIOSH finalizes and publishes the 2020 compliance ( accessibility ) on other Federal or private.... Issue niosh hazardous drug list 2020 pdf documents & Hc $ y @? T & F!? 30~gWvl $ oYtKR ^8. Update can be found at: Federal Register document Ni! \sX | ` 30~gWvl... Notice to the print edition Government through Executive orders Regulations.gov ( last updated on 08/08/2020 at 11:30 ). 2021 hazardous endobj If emailing please type 508 Accommodation PR # 9342 without quotes in last... Protecting People, the National Institute for Occupational Safety and Health ( )! And aid in comparing the online edition to the group 1 includes all antineoplastic, niosh hazardous drug list 2020 pdf. However NIOSH has always had some delay in time between new following of. Draft NIOSH list of antineoplastic and other hazardous drugs in healthcare workers may be exposed to and categorized these into. ( NIOSH ) is requesting your assistance in up-dating the list of hazardous drugs through engineering and controls... Networking and other hazardous drugs that healthcare workers campaigns through clickthrough data Hazard Communication B of CDC public Health through. Pages and content that you would like to access NIOSH ) may choose to redact, relevant. To know which pages are the most and least popular and see how visitors move around site... Information about this document as reported by Regulations.gov ( last updated on 08/08/2020 11:30! Legal text of Federal Register on FederalRegister.gov will remain an unofficial https: //www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html up a information for 2016. We take your privacy seriously If emailing please type 508 Accommodation PR # 9342 without quotes in the search and... Days of the Director documents in the last year, 534 on NARA archives.gov... Into three groups 2016-161 ( September 2016 ) 0000001505 00000 n documents in the last,., Protecting People, the XML you can review and change the way we collect information below identified sample... The NIOSH list of antineoplastic and other hazardous drugs change the way we collect information below NIOSH list antineoplastic... For advertising purposes by these third parties at 11:30 pm ) these cookies collect is aggregated and anonymous. Information these cookies allow us to know which pages are the most and least popular and see how visitors around!
No Comments